Jefferies Assumes Xenon Pharmaceuticals (XENE) at Buy, Sees +50-75% Upside on Phase 2b Epilepsy Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. CRWD
4. AVGO
5. ULTA
6. GTLB
7. USO
8. MDT
9. GOOGL
10. VEEV

Go back to Jefferies Assumes Xenon Pharmaceuticals (XENE) at Buy, Sees +50-75% Upside on Phase 2b Epilepsy Data
(NASDAQ: XENE) Delayed: 53.46 --0 (-0%)
Previous Close $53.46    52 Week High $9.75 
Open $53.46    52 Week Low $5.65 
Day High $53.46    P/E N/A 
Day Low $53.46    EPS $0.00 
Volume 208